Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Ontario Health Technology Assessment Series|April 22, 2014
Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational studyD J O'Reilly, J M Bowen, R J Sebaldt, et al.
The American Journal of Psychiatry|April 1, 1993
Further evidence that a placebo response to antidepressants can be identifiedF M Quitkin, J W Stewart, P J McGrath, et al.
Journal of Clinical Psychopharmacology|December 1, 1993
Chronic depression: response to placebo, imipramine, and phenelzineJ W Stewart, P J McGrath, F M Quitkin, et al.
Frontiers in Oncology|June 13, 2022
Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate CancerCaroline E Nunes-Xavier, Janire Mingo, Maite Emaldi, et al.
Journal of Molecular Biology|December 4, 2002
Differential affinity and cooperativity functions of the amino-terminal 70 residues of lambda integraseDibyendu Sarkar, Marco A Azaro, Hideki Aihara, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1987
c-myc expression in the thyroid. II: Thyrocytes and peripheral and intrathyroidal lymphocytes from patients with autoimmune thyroid diseaseM E Nunes, Y Y Djuh, R V Larocca, et al.
The American Journal of Psychiatry|April 1, 1993
Loss of drug effects during continuation therapyF M Quitkin, J W Stewart, P J McGrath, et al.
The British Journal of Psychiatry. Supplement|September 1, 1993
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placeboF M Quitkin, J W Stewart, P J McGrath, et al.
Plos One|December 30, 2016
The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node MetastasesPeio Errarte, Rosa Guarch, Rafael Pulido, et al.
Human Pathology|July 8, 2019
The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladderJulio Calvete, Gorka Larrinaga, Peio Errarte, et al.
Pageof 17